Australia: Oventus completes A$9.3m capital raise

Mel Bridges, chairman, Oventus

Sleep disorder device manufacturer Oventus has completed its A$9.3m (US$6.5m) capital raise on the ASX with an oversubscribed A$2.3m entitlement offer. It previously raised A$7m in a two tranche placement. The placement was co-led by Bell Potter Securities and Patersons Securities. Due to the oversubscription of the offer, the underwriters will not subscribe for any…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »